A study estimitating re-hospitalizations and deaths and cost reductions in HF patients who initiate sacubitril/valsartan in-hospital in Portugal
Latest Information Update: 20 Nov 2020
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Enalapril
- Indications Decompensated heart failure
- Focus Therapeutic Use
- 20 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research